Dr Richard Shaffer: Radiotherapy Expert for Dupuytren’s & Ledderhose

Dr Richard Shaffer is a Radiation Oncologist and a prominent expert in the use of radiotherapy for treating benign disease, including Dupuytren’s, Ledderhose, plantar fasciitis, Achilles tendinopathy, keloid scars, osteoarthritis, tendinopathy and bursitis.

Since starting his practice in 2011, Dr Shaffer has treated approximately 2,500 benign patients, and provided training and mentoring to fellow consultants starting benign radiotherapy practices. He co-wrote the 2015 Royal College of Radiologists guidelines for benign conditions and is the founder and President of the International Society for Radiotherapy for Benign Conditions (www.iorbc.com).

A middle-aged man with short gray hair, glasses, and a trimmed beard, wearing a navy blue button-up shirt, smiles at the camera—portraying optimism often seen in those seeking Dupuytrens contracture treatment UK.

Dr Shaffer's Background

Dr Shaffer is the UK Clinical Lead for Radiotherapy for benign conditions at GenesisCare. He is also Medical Director of XStrahl Limited. He has written and reviewed multiple scientific papers and textbook chapters and contributed to NICE consultations. He has previously been chair of the IMRT-IGRT Radiotherapy Group, the Network Brain Tumour Working Group, Clinical Lead for Radiotherapy at St Luke's Cancer Centre, and a trustee of the Fountain Centre (a local patient support charity).

In his early career, Dr Shaffer trained as a specialist registrar at various London teaching hospitals, and also completed a Clinical Fellowship in Radiation Oncology at the British Columbia Cancer Agency in Vancouver, Canada.

A professional and engaging image of Dr. Richard Shaffer, featuring his warm smile, distinctive glasses, and a classic dark shirt against a clean backdrop.
A modern hospital room with a large linear accelerator used for radiation therapy, featuring a treatment bed and equipment under bright overhead lighting—ideal for patients with conditions like Dupuytren’s contracture symptoms or Ledderhose disease.

Benign Radiotherapy Experience

  • 3000+ Patients (DD, LD, Keloids, Osteoarthritis, Tendinopathy, Bursitis)
  • Founder & President of IORBC (International Organisation for Radiotherapy for Benign Conditions)
  • Further Training in Germany (RT for OA and Tendinopathy)

NHS Consultant Oncologist

Brain, prostate, bladder, Skin cancer and benign

NHS training, 2010-2019 (General, Specialist)

Benign Radiotherapy Experience

3000+ Patients (DD, LD, Keloids, Osteoarthritis, Tendinopathy, Bursitis)

Founder & President of IORBC (International Organisation for Radiotherapy for Benign Conditions)

Further Training in Germany (RT for OA and Tendinopathy)

Research and Publications

Publications (Post-interventional RT for DD)

Royal College Guidelines on Benign Radiotherapy

BSSH, IFSSH (Presentations, Panels, Education)

Selected Publications

YEAR
Title
2025
Co-author of textbook chapter on Dupuytren Disease in Current Practice in Hand Surgery (Elsevier, 2025)
2024
Radiotherapy for Benign Conditions: A Swiss Patterns of Care Survey
2024
Poster presentation, ASTRO 2024 – “Low dose Radiation Therapy for Osteoarthritis: A Retrospective Single Institution Analysis of 51 patients and 85 joints”. B Koneru…. R.E. Shaffer.
2023
Radiotherapy for Footballers. Invited talk to Tottenham Hotspur FC medical team, 2023
2022
Radiotherapy for Benign Diseases. DEGRO guidelines 2022 (English translation).
2022
Treatment of Dupuytren’s Disease with Post-Interventional Radiotherapy. R. Shaffer and H. Seegenschmiedt. ASTRO (poster) 2022
2018
Outcomes of Radiotherapy for Ledderhose disease (Plantar Fibromatosis) of the feet. Richard Shaffer, Immanuel Jeevarathnam, Chelsea Freeland, Louise Pardon. ESTRO meeting (poster) 2018
2015
A review of the use of radiotherapy in the UK for the treatment of benign clinical conditions and benign tumours. Royal College of Radiologists 2015.
2015
Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. Stephanie McKeown, Paul Hatfield, Robin Prestwich, Richard Shaffer, Roger Taylor. British Journal of Radiology 2015; 88: 20150405.
A healthcare professional wearing green scrubs and blue gloves gently holds a patient’s hand, offering comfort and support during a medical consultation about Dupuytren’s contracture symptoms.

Here For You

These are some of the different experts and support staff who make up our teams. Your care will be led by a consultant oncologist who will work alongside our experienced team. Together, they will manage your personalised treatment and care plan.

  • Therapy Radiographer Involved in radiotherapy planning scans, treatment planning and delivering radiotherapy. You’ll see them at every radiotherapy session.
  • Dosimetrist Helps your oncologist plan your radiotherapy treatment while limiting damage to healthy tissues.
  • Physicist Measures the dose of radiation you receive during radiotherapy to ensure it is safe and as prescribed by your oncologist.
  • Patient Administration Officer Responsible for all administration relating to your care and treatment, including dealing with funding and insurance.
  • Receptionist Here to greet you, deal with any enquiries or changes to appointments.